METHODS:
l We have reviewed German e-health initiatives and assessed the requirements for available reimbursement pathways specifically for telemedicine initiatives in Germany and grouped them according to the application setting.
l Reimbursement application pathways for inpatient and outpatient e-health initiatives were evaluated by conducting a targeted literature search analysing the reimbursement pathways and requirements reported. 
RESULTS:
l Overall there are currently 289 e-health initiatives implemented in Germany in only few centers (mainly Berlin, Bad Oeynhausen, Munich, Hamburg). Telemedicine is being handled as medical devices in Germany within the market access pathway. The exact process depends if the device is an inpatient or outpatient product. In the inpatient setting relevant DRG and OPS codes are applicable; theoretically NUB and additional fee (Zusatzentgelt) could also be applied for.
In the outpatient setting, the reimbursement of e-health devices is driven through the respective catalogue of aids and appliances whereas the actual physician service would need to be reimbursed through the EBM (Einheitlicher Bewertungsmassstab).
l For the application of a new e-health in the outpatient sector a positive reimbursement decision is mandatory. The first strategy should be to apply for inclusion in the EBM (the uniform assessment standard of the physician's fee schedule) and GOÄ (physician's fee schedule for private health insurance provisions) fee schedules; or if applicable for inclusion in the HMV. It is mandatory to provide specific clinical and health economic evidence during the application process. Currently there is no specific EBM code available, and health politicians have missed a deadline in 2014 to create one. In the outpatient setting the EBM adaptation for e-health was not moved forward. G-BA members (physicians, health insurances) were not convinced updating the current outpatient codes or adding a new one. 'Selective Contracting' can be set up by all GKV'S (mandatory integral part), all health care providers, all management organizations in addition to GKV regular care (collective contracts). The choice of the contractual basis depends mainly on the content design of the selective contract for the special forms of health care; it is mandatory to provide specific clinical and health economic evidence during the application for an inclusion in the selected contract to the advisory board. l For eHealth initiatives selective contracts could be the opportunity for reimbursement. In order to qualify for such an initiative the individual company (preferably in combination with a care provider) would contact the health insurance(s). Selective contracts could cover any costs which would be agreed during the development of the contract. 
C OS T E F F IC IE NC Y
Containing cost increases Reducing healthcare service consumption over time Ensuring risk structure equalization (RSA) margins
OP T IMIZE D C AR E P R OC E S S
Adequate access to specialist Interconnection of ambulatory and stationary care process acceleration / workflow optimizing l Most telemedicine projects are currently being covered and tested in the latter ones (e. g. telemonitoring CHF, video Parkinson therapy). An alternative new route could also be the experimental coverage by the joint federal committee. To be applicable for the 'Experimental Coverage' program (reimbursement while additional evidence is generated in clinical trials) a new medical device needs to show a strong "potential"; this usually means it needs to be innovative in a patient population with a high unmet medical need in order to be eligible for reimbursement under the 'Experimental Coverage' program. l A device that enters the experimental coverage pathway and generates a positive study will be implemented into the regular care reimbursement.
-No further submissions are required and the G-BA will automatically start the process of allocating the respective reimbursement codes.
-The reimbursement codes will cover the physicians time allocated and the monitoring activity l Funding of the initial investment -Dependent on the investment required this would then be covered by the regional investment funds which are normally being negotiated between hospitals and the Bundesländer in Germany (regions).
l
The investments in infrastructure are negotiated for all products over a year and thus not product specific l Furthermore Disease Management Programmes (DMPs) driven by the G-BA could be another opportunity with payments outside of the regular reimbursement care.
CONCLUSION:
l Currently the most relevant market access pathway for telemedicine initiatives in Germany is through selective contracts. Once health politicians put e-health as a priority the introduction of specific DRG and EBM codes could initiate fast adaption and more telemedine introductions in Germany.
The poster is available on www.marketaccess-pricingstrategy.de
